Extent of Tumor Resection Linked to Long-Term Survival in Grade 2 Glioma
More complete tumor resection is associated with improved long-term outcomes in patients with IDH-mutant, grade 2 glioma.
More complete tumor resection is associated with improved long-term outcomes in patients with IDH-mutant, grade 2 glioma.
Patients undergoing cancer surgery have an increased risk of suicide compared with the general population, a new study suggests.
Research suggests hippocampal-sparing radiation may be feasible for pediatric patients with medulloblastoma because the risk of peri‐hippocampal recurrence is low.
In mouse models, WP1122 outperformed temozolomide.
Chronic convection-enhanced delivery of topotecan was feasible and well tolerated in patients with recurrent glioblastoma.
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
Adding an autologous tumor lysate-loaded dendritic cell vaccine to standard care improves survival in patients with glioblastoma, a phase 3 study suggests.
Young adult survivors of pediatric cancer experience significant premature aging, a retrospective study suggests.
Most recent phase 3 trials of patients with newly diagnosed glioblastoma have shown no significant improvement in overall survival with the experimental treatment.
Deaths among patients with primary malignant brain tumors are on the rise in the United States, data suggest.